Marshall Wace’s Akero Therapeutics AKRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.7M | Sell |
1,418,215
-189,627
| -12% | -$10.1M | 0.09% | 202 |
|
|
2025
Q1 | $65.1M | Buy |
1,607,842
+1,332,768
| +485% | +$54M | 0.08% | 200 |
|
|
2024
Q4 | $7.65M | Buy |
+275,074
| New | +$7.65M | 0.01% | 824 |
|
|
2024
Q2 | – | Sell |
-120,674
| Closed | -$3.05M | – | 2265 |
|
|
2024
Q1 | $3.05M | Buy |
+120,674
| New | +$3.05M | ﹤0.01% | 1049 |
|
|
2023
Q4 | – | Sell |
-260,535
| Closed | -$13.2M | – | 1800 |
|
|
2023
Q3 | $13.2M | Sell |
260,535
-662,523
| -72% | -$33.5M | 0.03% | 509 |
|
|
2023
Q2 | $43.1M | Sell |
923,058
-158,667
| -15% | -$7.41M | 0.08% | 231 |
|
|
2023
Q1 | $41.4M | Sell |
1,081,725
-421,639
| -28% | -$16.1M | 0.09% | 224 |
|
|
2022
Q4 | $82.4M | Buy |
1,503,364
+752,524
| +100% | +$41.2M | 0.19% | 105 |
|
|
2022
Q3 | $25.6M | Sell |
750,840
-254,842
| -25% | -$8.68M | 0.06% | 335 |
|
|
2022
Q2 | $9.5M | Buy |
+1,005,682
| New | +$9.5M | 0.02% | 843 |
|
|
2022
Q1 | – | Sell |
-4,082
| Closed | -$86K | – | 2565 |
|
|
2021
Q4 | $86K | Buy |
+4,082
| New | +$86K | ﹤0.01% | 2718 |
|
|
2020
Q2 | – | Sell |
-4,664
| Closed | -$99K | – | 1475 |
|
|
2020
Q1 | $99K | Buy |
+4,664
| New | +$99K | ﹤0.01% | 1309 |
|